DAPAGLIFLOZIN
Clinical Indication
With insulin for treating Type 1 diabetes, historic patients only
Comments
Now unlicensed due to commercial reasons
Date of classification
November 2019
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .